1. Home
  2. ELVN vs ONDS Comparison

ELVN vs ONDS Comparison

Compare ELVN & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

N/A

Current Price

$46.48

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Logo Ondas Holdings Inc.

ONDS

Ondas Holdings Inc.

N/A

Current Price

$3.78

Market Cap

3.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
ELVN
ONDS
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
ELVN
ONDS
Price
$46.48
$3.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
10
Target Price
★ $74.33
$16.68
AVG Volume (30 Days)
1.2M
★ 37.9M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 3.17
N/A
EPS
N/A
★ 0.27
Revenue
N/A
★ $50,731,000.00
Revenue This Year
N/A
$995.91
Revenue Next Year
N/A
$97.07
P/E Ratio
★ N/A
$15.70
Revenue Growth
N/A
★ 605.31
52 Week Low
$14.79
$4.21
52 Week High
$62.32
$15.28

Technical Indicators

Market Signals
Indicator
ELVN
ONDS
Relative Strength Index (RSI) 49.64 28.23
Support Level $44.18 N/A
Resistance Level $46.96 $11.77
Average True Range (ATR) 2.47 0.47
MACD -0.17 -0.13
Stochastic Oscillator 25.69 1.27

Price Performance

Historical Comparison
ELVN
ONDS

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About ONDS Ondas Holdings Inc.

Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.

Share on Social Networks: